LogoVislink2022_2.jpg
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 18, 2024 16:10 ET | Vislink Technologies, Inc.
Mt. Olive, NJ, June 18, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that effective June 17, 2024, Donald Gilliam was granted a...
NO16 NEUROONE LOGO_RGB.png
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 23, 2024 17:10 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
LogoVislink2022_2.jpg
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 13, 2024 16:05 ET | Vislink Technologies, Inc.
Mt. Olive, NJ, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that effective February 12, 2024, Adrian Lambert was granted a...
LogoVislink2022_2.jpg
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 02, 2024 17:23 ET | Vislink Technologies, Inc.
Mt. Olive, NJ, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that effective January 1, 2024, Bill Sweeney was granted a...
LogoVislink2022_2.jpg
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 07, 2023 16:30 ET | Vislink Technologies, Inc.
Mt. Olive, NJ, July 07, 2023 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that on July 5, 2023, Steven Teese was granted a time-based...
Atyr_Logo.png
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 12, 2022 16:05 ET | aTyr Pharma, Inc.
SAN DIEGO, Aug. 12, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on its proprietary...
Atyr_Logo.png
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 13, 2022 16:00 ET | aTyr Pharma, Inc.
SAN DIEGO, May 13, 2022 (GLOBE NEWSWIRE) --  aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on its proprietary...
Logo new.jpg
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 24, 2020 17:00 ET | Vislink Technologies, Inc.
HACKETTSTOWN, NJ, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. announced today that on January 22, 2020 Carleton Miller was granted a time-based and performance-based non-qualified...